HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julie D Saba Selected Research

Lymphopenia (Lymphocytopenia)

9/2021Genotype/Phenotype Interactions and First Steps Toward Targeted Therapy for Sphingosine Phosphate Lyase Insufficiency Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julie D Saba Research Topics

Disease

9Neoplasms (Cancer)
12/2014 - 01/2004
8Inflammation (Inflammations)
12/2017 - 03/2006
6Carcinogenesis
01/2017 - 12/2009
4Colonic Neoplasms (Colon Cancer)
12/2014 - 11/2006
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 01/2014
2Colitis-Associated Neoplasms
10/2015 - 01/2014
2Ischemia
01/2013 - 05/2011
2Adenoma (Adenomas)
09/2012 - 10/2006
2Cardiovascular Diseases (Cardiovascular Disease)
07/2010 - 04/2004
1Infections
04/2022
1Wounds and Injuries (Trauma)
09/2021
1Lymphopenia (Lymphocytopenia)
09/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2020
1Neuroblastoma
10/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2017
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
03/2017
1Nephrosis
03/2017
1Ichthyosis (Xeroderma)
03/2017
1Colitis
10/2015
1Neoplastic Cell Transformation
12/2014
1Polyps
09/2012
1Leukemia
11/2011
1Lymphoma (Lymphomas)
11/2011
1Hematologic Neoplasms (Hematological Malignancy)
11/2011
1Acute Lung Injury
08/2011
1Lung Injury
08/2011
1Edema (Dropsy)
08/2011
1Reperfusion Injury
05/2011
1Acute-Phase Reaction
03/2011
1Hypoxia (Hypoxemia)
06/2010
1Metabolic Diseases (Metabolic Disease)
04/2010
1Pathologic Neovascularization
03/2010
1Radiation Injuries (Radiation Sickness)
02/2010
1Autoimmune Diseases (Autoimmune Disease)
05/2007
1Lung Neoplasms (Lung Cancer)
12/2004
1Prostatic Neoplasms (Prostate Cancer)
12/2004

Drug/Important Bio-Agent (IBA)

16sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
09/2021 - 01/2004
11SphingolipidsIBA
09/2021 - 12/2004
6sphingosine 1-phosphate lyase (aldolase)IBA
03/2017 - 01/2004
5EnzymesIBA
01/2020 - 01/2010
5LipidsIBA
01/2017 - 01/2010
4LyasesIBA
03/2017 - 03/2011
3CytokinesIBA
12/2017 - 03/2011
3CeramidesIBA
11/2011 - 01/2004
2Biological ProductsIBA
01/2017 - 04/2004
2Sphingosine-1-Phosphate ReceptorsIBA
12/2014 - 03/2011
1Antiviral Agents (Antivirals)IBA
04/2022
1Interferon Type IIBA
04/2022
1Vitamin B 6IBA
01/2020
1VitaminsIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2018
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2015
1NF-kappa B (NF-kB)IBA
10/2015
1MicroRNAs (MicroRNA)IBA
12/2014
1CateninsIBA
09/2012
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
09/2012
1Sirolimus (Rapamycin)FDA Link
09/2012
1calyculin AIBA
09/2012
1Okadaic AcidIBA
09/2012
1imidazoleIBA
08/2011
1Biomarkers (Surrogate Marker)IBA
02/2010
1Pharmaceutical PreparationsIBA
01/2010
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2006
1sphingosine kinaseIBA
10/2006
1SphingosineIBA
10/2006
1Vitamin EFDA LinkGeneric
12/2004
1alpha-TocopherolFDA Link
12/2004
1gamma-TocopherolIBA
12/2004
1Immunologic Factors (Immunomodulators)IBA
01/2004

Therapy/Procedure

3Therapeutics
10/2018 - 06/2010
2Drug Therapy (Chemotherapy)
01/2013 - 11/2011
1Oral Administration
12/2014
1Chemoprevention
05/2007
1Transplantation
05/2007